GSK Investigational Site

Abington, Pennsylvania 19001-3788

0 studies enrolling now · 4 studies all time

What they study most

Acute Coronary Syndrome, Fallopian Tube Cancer, Neoplasms, Ovarian, Ovarian Cancer, Ovarian Neoplasms, Peritoneal Cancer, Platinum Sensitive Ovarian Cancer

Studies at this site

• A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer — Completed
• Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer — Completed
• A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60) — Completed
• Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer — Completed